Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma.
microvascular invasion
tumor marker
α-fetoproteingradient
Journal
Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
01
04
2019
accepted:
23
09
2019
entrez:
18
2
2020
pubmed:
18
2
2020
medline:
18
2
2020
Statut:
ppublish
Résumé
Although vascular invasion is an important factor in the progression and treatment of hepatocellular carcinoma (HCC), it remains difficult to determine, on the basis of preoperative imaging alone, whether vascular invasion, especially microvascular invasion, has occurred. The current retrospective study enrolled 292 patients who, between 2004 and 2014, underwent curative hepatectomy as an initial treatment for HCC. The patients were divided between those with (n=70) and those without (n=222) microvascular invasion. Whether tumor-marker-based prediction of microvascular invasion was possible was assessed by comparing the preoperative serum α-fetoprotein (AFP) and prothrombin induced by vitamin K absence or antagonist-II concentrations between two groups of patients. The AFP concentration was significantly higher in patients with microvascular invasion compared with patients without microvascular invasion (P=0.0019). Stepwise logistic regression analysis demonstrated the AFP concentration and the logarithmic conversion ratio of the AFP gradient (log AFP grad) to be useful (P=0.0019; 0.0424) for predicting microvascular invasion. The serum AFP concentration and log AFP grad appear to be clinically useful in predicting microvascular invasion in patients with HCC.
Identifiants
pubmed: 32064109
doi: 10.3892/mco.2020.1975
pii: MCO-0-0-1975
pmc: PMC7016610
doi:
Types de publication
Journal Article
Langues
eng
Pagination
290-294Informations de copyright
Copyright © 2019, Spandidos Publications.
Références
J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):575-85
pubmed: 21360083
Am J Surg. 2012 Sep;204(3):300-7
pubmed: 22591698
Hepatol Res. 2014 Aug;44(8):846-53
pubmed: 23834279
J Surg Oncol. 2010 Oct 1;102(5):462-8
pubmed: 20872949
J Adv Res. 2013 Nov;4(6):539-46
pubmed: 25685463
Am J Surg. 2007 Apr;193(4):431-7
pubmed: 17368283
World J Surg. 2004 Jul;28(7):702-7
pubmed: 15185000
Liver Int. 2011 Jan;31(1):22-35
pubmed: 20874725